IL-FOURKITES
14.3.2024 12:31:31 CET | Business Wire | Press release
Leading real-time supply chain visibility provider FourKites® today announced the promotion of Priya Rajagopalan to President of Product, Technology and Operations, as well as the appointment of Ron Richardson as Chief Revenue Officer (CRO). These appointments underscore FourKites’ focus on rapid growth and innovation, with an eye toward solving customers’ most pressing needs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240314808596/en/
FourKites promotes Priya Rajagopalan to President of Product, Technology and Operations and appoints Ron Richardson as Chief Revenue Officer to drive industry adoption and accelerate customer value (Photo: Business Wire)
Priya Rajagopalan leads FourKites’ Product, Engineering and Customer functions, with the goal of aligning customer needs and the company’s innovation engine to drive maximum customer value. Rajagopalan joined FourKites seven years ago as Chief Product Officer, bringing with her a wealth of experience in product management from various startups and public companies. Currently, Rajagopalan also serves on the Board of Directors of Brambles (ASX: BXB), the supply-chain logistics company operating across 60 countries through the CHEP brand. A testament to her industry contributions, she has been named an SDCE Pros to Know, and one of The Software Report’s Top 25 Software Product Executives.
Under Rajagopalan’s direction, FourKites has rolled out a number of industry-first product innovations, including real-time facility manager Dynamic Yard; end-to-end international ocean shipments tracker Dynamic Ocean; generative AI assistant Fin AI; patented AI-powered ETA forecaster Smart Forecasted Arrival; universal appointment scheduler Appointment Manager; and others.
“FourKites defined and created the supply chain visibility category, and innovating with customers has been, and continues to be part of our company’s DNA,” said Rajagopalan. “This alignment allows us to innovate and execute at even greater speed to ensure successful deployment and adoption across our customers."
Ron Richardson returns to FourKites as CRO, where he leads Sales, Partners and Alliances to drive FourKites’ global momentum. Ron recently served as CRO at OneRail, a solution that has redefined last-mile delivery, as well as CRO at Turvo, where he helped scale the company revenue and position it for a successful exit. Previously, Richardson was one of FourKites’ first employees, where he was instrumental in creating the real-time transportation visibility platform (RTTVP) category, building the business and closing some of the company’s earliest customer deals, including Coca-Cola, Nestlé and many more.
“I am thrilled to come back home to FourKites — returning to the market-leading company and the industry category I helped pioneer,” said Richardson. “I look forward to building on the momentum the team and I jump-started in the early years, driving growth and success among our Fortune 500 enterprise customers who continue to see massive value with the FourKites platform.”
“These promotions reflect our confidence in Priya’s and Ron’s leadership and their ability to propel FourKites to even greater heights,” said FourKites founder and CEO Mathew Elenjickal. “Priya’s unique blend of deep technical knowledge, innate leadership skills and collaborative approach has earned her admiration from industry leaders, investors and customers alike. Likewise, Ron brings deep industry experience, a strong track record as a successful CRO and, most importantly, vast knowledge of our existing customers and ecosystem. Under their leadership, we will continue to innovate, grow and solidify our position as the de-facto leader in the supply chain visibility space.”
About FourKites
Leading global supply chain visibility platform FourKites® empowers business leaders with comprehensive visibility into transportation, yards, warehouses, stores and beyond. Tracking more than 3.2 million shipments daily across road, rail, ocean, air, parcel and last mile, and reaching over 200 countries and territories, FourKites combines real-time data and powerful machine learning to help companies digitize their end-to-end supply chains. More than 1,500 of the world’s most recognized brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240314808596/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
